1 |
Hu, G., Qiao, Q., Tuomilehto, J., Balkau, B., Borch-Johnsen, K., and Pyorala, K. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164, 1066-1076.
DOI
|
2 |
Azizi, F., Salehi, P., Etemadi, A., and Zahedi-Asl, S. (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61, 29-37.
DOI
|
3 |
Onat, A., Ceyhan, K., Basar, O., Erer, B., Toprak, S., and Sansoy, V. (2002). Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165, 285-292.
DOI
ScienceOn
|
4 |
Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V.P., and Kothari, K. (2003). Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 61, 69-76.
DOI
ScienceOn
|
5 |
Wisse, B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800.
DOI
ScienceOn
|
6 |
Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., Takishita, S. (2004): Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876.
DOI
ScienceOn
|
7 |
Ejerblad, E., Fored, M., Lindblad, P., Fryzek, J., McLaughlin, J.K., and Nyren, O. (2006). Obesity and risk of chronic renal failure. J Am Soc Nephrol 17, 1695-1702.
DOI
|
8 |
Filler, G., Boken Kamp, A., Hotmann, W., Le Bricon, T., Martnez-Bru, C., and Grubb, A. (2005). Cystatin C as marker of GFR, history indication and future research. Clin Biochem 38, 1-8.
DOI
|
9 |
Henskens, Y.M.C., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1996). Cystatins in health and disease. Biol Chem Hoppe-Seyler 377, 71-86.
|
10 |
Sarnak, M.J., Katz, R., Stehman-Breen, C.O., Fried, L.F., Nancy Swords Jenny, Bruce, M.P., Newman, A., Siscovick, D., Shlipak, M; The Cardiovascular Health Study. (2005). Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults. Ann Intern Med 142, 497-505.
DOI
|
11 |
O'Hare, A., Newman, A., Katz, R., Fried, L., Stehman-Breen, C., Seliger, S., Siscovick, D., Shlipak, M.S., and Cystatin, C. (2005). Incident peripheral arterial disease events in the elderly. Arch Intern Med 165, 2666- 2670.
DOI
|
12 |
Hoehner, C.M., Greenlund, K.J., Rith-Najarian, S., Casper, M.L., and McClellan, W.M. (2002). Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter- Tribal Heart Project. J Am Soc Nephrol 13, 1626-1634.
DOI
ScienceOn
|
13 |
Hsu, C.Y., McCulloch, C.E., Iribarren, C., Darbinian, J., and Go, A.S. (2006). Body mass index and risk for end-stage renal disease. Ann Intern Med 144, 21-28.
DOI
|
14 |
Armstrong, K.A, Campbell, S.B, Hawley, C.M., Nicol, D.L, Johson, D.W., and Isbel, N.M. (2005). Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 5, 2710-2718.
DOI
|
15 |
Agnani, S., Vachharajani, V.T, Gupta, R., Atray, N.K., and Vachharajani, T.J. (2005). Does treating obesity stabilize chronic kidney disease? BMC Nephrol 6, 7.
DOI
|
16 |
Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., and Ori, Y. (2003). The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14, 1480-1486.
DOI
ScienceOn
|
17 |
Kambham, N., Markowitz, G.S., Valeri, A.M., Lin, J., and D'Agati, V.D. (2001). Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59, 1498-1509.
DOI
ScienceOn
|
18 |
Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91.
DOI
ScienceOn
|
19 |
Wisse. B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800
DOI
ScienceOn
|
20 |
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. (2005). Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454.
DOI
ScienceOn
|